Blood proteins may flag disability risk years before loss of independence
· Medical Xpressedited by Sadie Harley, reviewed by Robert Egan
Sadie Harley
Scientific Editor
Meet our editorial team
Behind our editorial process
Robert Egan
Senior Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
trusted source
proofread
The GIST Add as preferred source
Japan has one of the world's fastest-aging populations, but maintaining independence into very old age remains a growing public health challenge. Nearly 60% of Japanese adults aged 85 years and older already receive support through the national Long-Term Care Insurance system, highlighting the need to identify people at risk before disability develops.
Although routine blood tests can detect many age-related diseases, reliable biomarkers that predict future disability in the oldest-old have remained elusive. Identifying such markers could enable earlier interventions that help older adults remain active and independent for longer.
Addressing this challenge, a research team led by associate professor Yusuke Osawa from the Graduate School of Health Management at Keio University in Japan, along with Professor Yasumichi Arai from the Faculty of Nursing and Medical Care at the same university and Dr. Luigi Ferrucci, scientific director of the Translational Gerontology Branch at the National Institute on Aging, National Institutes of Health, analyzed blood samples from community-dwelling adults aged 85–89 years using an unbiased, data-driven screen of circulating proteins.
Using machine learning and multivariable statistical analyses, they evaluated 29 plasma proteins for associations with future disability and mortality before independently validating the findings in the Italian Invecchiare in Chianti (InCHIANTI) aging study.
The study was published online in the journal GeroScience.
Two proteins stood out
The discovery analysis included 230 disability-free participants from the Kawasaki Aging Well-being Project (KAWP), who were followed for approximately 4.5 years. Higher levels of beta-2-microglobulin (B2M) and cystatin C were consistently associated with a greater likelihood of developing disability.
Each increase in these biomarkers was associated with significantly higher disability risk (hazard ratio 1.35 for B2M and 1.42 for cystatin C), even after accounting for age, sex, kidney function, lifestyle factors and other potential confounders.
To determine whether the findings extended beyond one population, the researchers examined participants in the InCHIANTI study, which followed older adults in Italy for up to 15 years. Elevated B2M and cystatin C levels were again associated with greater disability risk, particularly among participants aged 80 years and older.
In contrast, proteins initially linked with mortality—including epidermal growth factor and interferon gamma-induced protein 10—were not replicated, indicating that the disability-related biomarkers were the study's most consistent findings.
Clues to decline before dependence
"Because B2M and cystatin C are already measurable using standard clinical assays, they have the potential to become practical tools for identifying older adults who may benefit from preventive support," Osawa says.
The two proteins also provide important biological insights. Both are associated with kidney function, while B2M additionally reflects chronic low-grade inflammation, or "inflammaging," which is increasingly recognized as a driver of age-related decline. Together, these processes may contribute to the gradual loss of physical function that ultimately leads to dependence on long-term care.
"Our findings suggest that preserving healthy aging requires attention not only to diseases but also to the biological processes that precede disability," Arai explains. "Earlier identification of people at higher risk could create opportunities for timely interventions such as exercise, nutritional support and rehabilitation before irreversible decline occurs."
Overall, the study identifies B2M and cystatin C as promising blood-based biomarkers of future disability in very old adults. Their validation across Japanese and Italian cohorts supports their potential use in earlier risk stratification in rapidly aging societies.
Such an approach may help shift health care from reactive treatment toward proactive prevention, enabling more older adults to maintain their independence while reducing the growing burden on long-term care systems worldwide.
More information
Yusuke Osawa et al, Plasma proteins associated with disability and mortality risks in Japanese community-dwelling octogenarians, GeroScience (2026). DOI: 10.1007/s11357-026-02377-7
Key medical concepts
beta 2-MicroglobulinCystatin CDisability typeRenal Function
Clinical categories
Geriatric palliative careHealthy agingCommon illnesses & Prevention Provided by Keio University Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Blood proteins may flag disability risk years before loss of independence (2026, August 21) retrieved 21 August 2026 from https://medicalxpress.com/news/2026-08-blood-proteins-flag-disability-years.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.